Scalar Gauge Management LLC Decreases Stake in Cellebrite DI Ltd. $CLBT

Scalar Gauge Management LLC lowered its position in shares of Cellebrite DI Ltd. (NASDAQ:CLBT) by 63.2% during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 132,210 shares of the company’s stock after selling 227,030 shares during the quarter. Cellebrite DI accounts for approximately 1.2% of Scalar Gauge Management LLC’s investment portfolio, making the stock its 23rd biggest holding. Scalar Gauge Management LLC owned 0.06% of Cellebrite DI worth $2,115,000 at the end of the most recent quarter.

Several other institutional investors also recently modified their holdings of the business. Envestnet Asset Management Inc. purchased a new stake in shares of Cellebrite DI during the first quarter valued at approximately $512,000. Allianz Asset Management GmbH bought a new position in Cellebrite DI in the 1st quarter valued at $476,000. KLP Kapitalforvaltning AS increased its position in shares of Cellebrite DI by 62.9% during the 1st quarter. KLP Kapitalforvaltning AS now owns 22,800 shares of the company’s stock valued at $443,000 after purchasing an additional 8,800 shares during the last quarter. Assetmark Inc. purchased a new stake in shares of Cellebrite DI during the 1st quarter valued at $33,000. Finally, TD Asset Management Inc raised its stake in shares of Cellebrite DI by 909.6% during the 1st quarter. TD Asset Management Inc now owns 106,306 shares of the company’s stock worth $2,066,000 after purchasing an additional 95,777 shares during the period. 45.88% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several research firms recently weighed in on CLBT. Needham & Company LLC increased their price target on shares of Cellebrite DI from $22.00 to $24.00 and gave the company a “buy” rating in a research report on Thursday, November 13th. Bank of America increased their target price on shares of Cellebrite DI from $24.00 to $25.00 and gave the company a “buy” rating in a research report on Thursday, November 13th. Lake Street Capital raised their price target on shares of Cellebrite DI from $22.00 to $23.00 and gave the stock a “buy” rating in a research note on Thursday, November 13th. Wall Street Zen cut shares of Cellebrite DI from a “buy” rating to a “hold” rating in a report on Saturday, November 8th. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of Cellebrite DI in a research note on Wednesday, November 19th. Four research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, Cellebrite DI has an average rating of “Moderate Buy” and a consensus target price of $24.00.

Cellebrite DI Price Performance

CLBT opened at $16.88 on Tuesday. The firm has a 50-day moving average price of $17.86 and a 200-day moving average price of $16.57. Cellebrite DI Ltd. has a twelve month low of $13.10 and a twelve month high of $26.30. The company has a market capitalization of $4.04 billion, a price-to-earnings ratio of -22.21, a PEG ratio of 3.16 and a beta of 1.28.

Cellebrite DI (NASDAQ:CLBT) last announced its quarterly earnings results on Wednesday, November 12th. The company reported $0.08 EPS for the quarter, missing analysts’ consensus estimates of $0.13 by ($0.05). Cellebrite DI had a negative net margin of 34.56% and a positive return on equity of 23.92%. The business had revenue of $126.03 million for the quarter, compared to analysts’ expectations of $122.98 million. During the same quarter in the previous year, the company posted $0.14 earnings per share. The business’s quarterly revenue was up 17.9% compared to the same quarter last year. Cellebrite DI has set its FY 2025 guidance at EPS. Q4 2025 guidance at EPS. On average, sell-side analysts expect that Cellebrite DI Ltd. will post 0.3 earnings per share for the current fiscal year.

Cellebrite DI Company Profile

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.